RBDCOV Talks is a ten-episode series where RBDCOV's leading scientists, researchers, medical professionals and community advocates will take us on a knowledge-packed journey to explore and discuss the world of vaccine clinical trials. In these episodes, we will understand how vaccine clinical trials work and talk through interesting topics such as inclusion criteria in a vaccine clinical trial, personalised vaccines and what exactly immunological memory is.
RBDCOV Talks
Claim This Podcastby RBDCOV
5.0(3 reviews)
13 episodes
Updated Inactive
Accepts GuestsHas Sponsors
Podcast Overview
RBDCOV Talks is a ten-episode series where RBDCOV's leading scientists, researchers, medical professionals and community advocates will take us on a knowledge-packed journey to explore and discuss the world of vaccine clinical trials. In these episodes, we will understand how vaccine clinical trials work and talk through interesting topics such as inclusion criteria in a vaccine clinical trial, personalised vaccines and what exactly immunological memory is.
Language
🇺🇲
Publishing Since
11/21/2023
1 verified contact email on file for RBDCOV Talks
Pitch yourself as a guest, propose sponsorships, or reach out directly to the host.
Recent Episodes
August 26, 2025
Lessons Learned: insights, learnings, and takeaways.
As RBDCOV nears its end, what have we truly learned? 📚 Laura Ferrer from HIPRA reflects on the key takeaways, lessons, and insights gained throughout the project—from challenges to breakthroughs.
August 26, 2025
The Psychosocial Perspective: what participants teach us.
💬 What motivated participants to join? How did they experience the process? And what lessons can we learn from their stories? Join Daniela Rojas Castro from EATG, who has played a leading role in ensuring that the voices of affected communities are not just heard, but actively shape the direction of the project.
August 26, 2025
It Starts and Ends With Us: Community at the Centre of Research.
How the community engagement campaign was built and why inclusion and diversity in clinical research are more than buzzwords they’re essential for impact? Let’s take a closer look with Tania Sanchis and Apostolos Kalogiannis from EATG, as they share insights about the campaign.
13 total episodes available
Deep-dive analytics for RBDCOV Talks
Frequently asked questions
Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.
- What is RBDCOV Talks?
- How often does this podcast release new episodes?
This podcast updates inactive.
- Where can I listen to this podcast?
This podcast is available on 4 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.
- Does this podcast accept guests?
Yes, this podcast regularly features guests.
Legal Disclaimer
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.